Syndax Pharmaceuticals In...

NASDAQ: SNDX · Real-Time Price · USD
15.63
0.90 (6.11%)
At close: Aug 15, 2025, 1:21 PM

Syndax Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-3.55 -7.25 -10.76 45.72
PEG Ratio
-0.14 -0.28 0.02 -0.36
PS Ratio
47.80 n/a n/a 8.16
PB Ratio
3.93 2.74 3.31 2.79
P/FCF Ratio
-4.12 -9.45 -11.55 39.30
P/OCF Ratio
-4.12 -9.45 -11.57 39.12
OCF/S Ratio
-11.61 n/a n/a 0.21
Debt / Equity Ratio
1.20 0.00 0.00 0.05
Quick Ratio
5.82 10.00 16.70 21.31
Current Ratio
5.82 10.00 16.56 21.68
Asset Turnover
0.03 n/a n/a 0.31
Interest Coverage
-68.91 -1.11K -48.38 13.81
Return on Equity
-1.11 -0.38 -0.31 0.06
Return on Assets
-0.44 -0.34 -0.29 0.06
Return on Invested Capital
-0.54 -0.41 -0.31 0.06
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.97 n/a n/a 1.00
Net Profit Margin
-13.46 n/a n/a 0.18
Pretax Profit Margin
-13.46 n/a n/a 0.18
Operating Profit Margin
-14.34 n/a n/a 0.19
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-13.25 n/a n/a 0.20